Biophytis (EPA:ALBPS) | Finanzwire

Basculer en Français

10056	Companies
205517	Keywords
135740	Articles
108951	Press releases

Home
Companies
Biophytis

BRIEF

published on 03/13/2026 at 07:35, 7 days 5 hours ago

Biophytis Unveils Obesity and Sarcopenia Programs at ICFSR Conference

Biophytis Clinical Research Sarcopenia ICFSR Conference Obesity
REGULATED PRESS RELEASE

published on 03/13/2026 at 07:30, 7 days 5 hours ago

BIOPHYTIS PRESENTS ITS DEVELOPMENT PROGRAMS IN OBESITY AND SARCOPENIA AT THE ICFSR CONFERENCE
Biophytis presents its development programs in obesity and sarcopenia at the ICFSR conference, showcasing BIO101 in obesity and SARA program in sarcopenia

Biophytis Clinical Research Sarcopenia ICFSR Conference Obesity
PRESS RELEASE

published on 03/13/2026 at 07:29, 7 days 5 hours ago

BIOPHYTIS PRESENTS ITS DEVELOPMENT PROGRAMS IN OBESITY AND SARCOPENIA AT THE ICFSR CONFERENCE
Biophytis presents its obesity and sarcopenia development programs at ICFSR Conference, highlighting clinical trials on healthy longevity and innovative therapies

Biophytis Clinical Research Sarcopenia ICFSR Conference Obesity
BRIEF

published on 03/12/2026 at 09:42, 8 days 2 hours ago

Biophytis raises €2 million in funding

Biophytis Fundraising Joint Venture Debt Repayment Sarcopenia
PRESS RELEASE

published on 03/12/2026 at 09:37, 8 days 3 hours ago

BIOPHYTIS ANNOUNCES COMPLETION OF OVER €2.0 MILLION CAPITAL INCREASE AND THE REPAYMENT OF ALL VARIABLE PRICE CONVERTIBLE DEBT
Biophytis completes a €2.0 million capital increase, repays variable price convertible debt, and plans to focus on clinical development in sarcopenia and obesity. Key investors include Alumni Capital Management, Bigger Capital, and Hexagon Capital Fund

Biophytis Capital Increase Sarcopenia Obesity Convertible Debt
BRIEF

published on 03/12/2026 at 07:35, 8 days 5 hours ago

Biophytis Expands AI Partnership with LynxKite for Longevity Drug Discovery

Biophytis Drug Discovery Longevity Sarcopenia LynxKite
REGULATED PRESS RELEASE

published on 03/12/2026 at 07:30, 8 days 5 hours ago

Biophytis-LynxKite Alliance Expands to Turbocharge AI-driven drug discovery for next generation longevity therapeutics
Biophytis and LynxKite form alliance to boost AI-driven drug discovery for longevity therapies, targeting sarcopenia and AMD

Biophytis Sarcopenia AI-driven Drug Discovery LynxKite Longevity Therapeutics
BRIEF

published on 03/11/2026 at 08:05, 9 days 4 hours ago

Biophytis Completes €2.0 Million Capital Increase

Biophytis Clinical Trials Capital Increase Sarcopenia Convertible Debt
REGULATED PRESS RELEASE

published on 03/11/2026 at 08:00, 9 days 4 hours ago

BIOPHYTIS ANNOUNCES COMPLETION OF OVER €2.0 MILLION CAPITAL INCREASE AND THE REPAYMENT OF ALL VARIABLE PRICE CONVERTIBLE DEBT
Biophytis completes over €2.0 million capital increase and repays all variable price convertible debt, attracting investments from U.S. healthcare institutions and strengthening financial structure for clinical development in sarcopenia and obesity

Biophytis Healthcare Institutions Capital Increase Clinical Development Convertible Debt
BRIEF

published on 02/27/2026 at 23:05, 20 days 13 hours ago

Biophytis Expands Bond Facility with Hexagon Capital to €2 Million

Biophytis Clinical Development Financial Strategy Hexagon Capital Bond Facility

Accesswire

Published on 03/20/2026 at 12:30, 9 minutes ago

CANEX Metals Announces the Numbers of Gold Basin Shares Taken up by Canex Metals
Published on 03/20/2026 at 12:00, 39 minutes ago

Organto Foods Inc. Announces Marketing Engagements with VSA Capital Limited and Venture Liquidity Partner Ltd.
Published on 03/20/2026 at 03:10, 9 hours 29 minutes ago

Future Fuels Announces Filing of Amended and Restated Life Offering Document
Published on 03/20/2026 at 00:20, 12 hours 19 minutes ago

Prospect Ridge To Host Investor Webinar With Presentation And Audience Q&A
Published on 03/20/2026 at 00:20, 12 hours 19 minutes ago

Reeflex Solutions Inc. Announces Revocation of Management Cease Trade Order

View all ACCESSWIRE

EQS Group

Published on 03/20/2026 at 11:56, 43 minutes ago

Amundi Physical Metals plc: UK Final Terms
Published on 03/20/2026 at 11:54, 44 minutes ago

Amundi Physical Metals plc: Final Terms
Published on 03/20/2026 at 11:30, 1 hour 9 minutes ago

Infosys and Formula E Launch AI-Powered Race Centre, Taking Fan Experience to Pole Position
Published on 03/20/2026 at 11:22, 1 hour 16 minutes ago

Original-Research: Warimpex Finanz- und Beteiligungs AG (von East Value Research GmbH ):
Published on 03/20/2026 at 11:10, 1 hour 29 minutes ago

LUDWIG BECK – Consolidated financial statements as of December 31, 2025

Les Echos

Published on 03/19/2026 at 18:00, 18 hours 39 minutes ago

Filing of the 2025 Universal Registration Document
Published on 03/19/2026 at 15:00, 21 hours 39 minutes ago

Statement Accor
Published on 03/19/2026 at 08:45, 1 day 3 hours ago

Deezer and Sonos renew and expand long-term collaboration
Published on 03/19/2026 at 07:00, 1 day 5 hours ago

bioMérieux Receives IVDR CE‑Marking for Two BIOFIRE® SPOTFIRE® Panels to Strengthen Near‑Patient Respiratory and Sore Throat Diagnostics Across Europe
Published on 03/19/2026 at 07:00, 1 day 5 hours ago

2025 Annual results and new strategic signature

View all LES ECHOS COMFI WIRE